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Abstract
Background: Probiotics appear to be beneficial in inflammatory bowel disease, but their mechanism of action is
incompletely understood. We investigated whether probiotic-derived sphingomyelinase mediates this beneficial effect.
Methodology/Principal Findings: Neutral sphingomyelinase (NSMase) activity was measured in sonicates of the probiotic L.
brevis (LB) and S. thermophilus (ST) and the non-probiotic E. coli (EC) and E. faecalis (EF). Lamina propria mononuclear cells
(LPMC) were obtained from patients with Crohn’s disease (CD) and Ulcerative Colitis (UC), and peripheral blood
mononuclear cells (PBMC) from healthy volunteers, analysing LPMC and PBMC apoptosis susceptibility, reactive oxygen
species (ROS) generation and JNK activation. In some experiments, sonicates were preincubated with GSH or GW4869, a
specific NSMase inhibitor. NSMase activity of LB and ST was 10-fold that of EC and EF sonicates. LB and ST sonicates induced
significantly more apoptosis of CD and UC than control LPMC, whereas EC and EF sonicates failed to induce apoptosis. Pre-
stimulation with anti-CD3/CD28 induced a significant and time-dependent increase in LB-induced apoptosis of LPMC and
PBMC. Exposure to LB sonicates resulted in JNK activation and ROS production by LPMC. NSMase activity of LB sonicates was
completely abrogated by GW4869, causing a dose-dependent reduction of LB-induced apoptosis. LB and ST selectively
induced immune cell apoptosis, an effect dependent on the degree of cell activation and mediated by bacterial NSMase.
Conclusions: These results suggest that induction of immune cell apoptosis is a mechanism of action of some probiotics,
and that NSMase-mediated ceramide generation contributes to the therapeutic effects of probiotics.
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Introduction
Probiotics are defined as live, non-pathogenic bacteria that
confer health benefits beyond their nutritional value [1]. A
growing body of evidence, accumulated in the last decade, suggests
that probiotics can be useful in the treatment of inflammatory
bowel disease (IBD), especially in patients with ulcerative colitis
(UC) and pouchitis [2–4]. In spite of this clinical evidence, our
understanding of the biological processes involved in the beneficial
effects of probiotics is still limited. Several mechanisms have been
postulated to contribute to the anti-inflammatory effect of
probiotics in the gut, including competitive exclusion of pathogens,
production of antimicrobial agents and organic acids, enhance-
ment of the epithelial barrier function, increase of mucosal IgA
secretion, and modulation of lymphocyte and dendritic cell
function [5–6]. Abnormalities of T cell function are recognized
to play a central role in IBD pathogenesis [7]. Among them,
resistance of mucosal T-cells to undergo apoptosis is believed to be
a critical event by altering the equilibrium between cell death and
proliferation resulting in an excessive accumulation of T-cells in
the gut [8–11]. The pathogenic importance of defective T-cell
apoptosis is supported by the observation that various drugs
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effective in the treatment of CD promote immune cell apoptosis
[12–16]. This has led to the notion that induction of apoptosis in
the mucosal immune compartment is a key step for successful
treatment of IBD [17]. Apoptosis is induced by multiple factors
and mediated by various mechanisms [18]. One of them involves
sphingomyelinases, a group of enzymes responsible for the
conversion of sphingomyelin into ceramide, a powerful second
messenger which mediates all forms of apoptosis, including
receptor-mediated, stress-induced, and cell detachment [19].
Three main families of sphingomyelinases have been described,
acidic (ASMase), alkaline and neutral (NSMase), according to their
optimal pH [20,21]. In relation to probiotics, recent observations
described that VSL#3, a probiotic that contains a mixture of eight
different strains of bacteria, stimulated mucosal alkaline sphingo-
myelinase activity, although the molecular downstream targets
contributing to the therapeutic effect of VSL#3 were not
elucidated [22]. NSMAse is also found in bacteria, yeast and
mammalian cells, and is a membrane-bound in mammalian cells
but a soluble protein in bacterial cells, with great variations in
NSMAse concentrations among different bacterial strains [23].
Since the role of NSMase in the therapeutic benefits of probiotics
has not been previously reported and because a large number of
bacteria produce NSMase [24] and probiotics can induce
apoptosis [25], we hypothesised that the probiotic strains used in
the management of IBD might exert an anti-inflammatory effect
by inducing immune cell death. If present in adequate concen-
trations, probiotic NSMase could induce ceramide formation and
trigger signalling pathways leading to apoptosis of lamina propria
mononuclear cells (LPMC) in patients with IBD, counterbalancing
the defective immune cell death. Therefore, the specific aim of this
study was to investigate the capacity of probiotics to produce
NSMase, and induce ceramide-mediated immune cell apoptosis.
Our data indicate that bacterial NSMase-mediated ceramide
generation induced immune cell apoptosis via JNK activation and
ROS overgeneration, two known targets of ceramide action.
Results
Increased NSMase activity in probiotic bacteria
Considering that several strains of bacteria can produce
different amounts of NSMase [24], we initially measured the
NSMase activity in each one of the probiotic and non-probiotic
sonicates used in our study. S. thermophilus and L Brevis exhibit well
documented probiotic properties and are considered probiotic
bacteria. S. thermophilus is one of the components of the probiotic
mixture VSL#3, which has been used in the treatment of
pouchitis and ulcerative colitis, among other conditions [2,3]. As
measured by HPTLC analysis, the sphingomyelinase activity of
the two probiotic bacteria, L. brevis and S. thermophilus, was
approximately ten-fold higher (p,0.01) than that of the two non-
probiotic commensal bacteria E. coli and E. faecalis (Fig. 1).
Determination of ASMase activities indicated similar levels of
activation in sonicates of probiotic and non-probiotic commensal
bacteria (data not shown).
Induction of LPMC apoptosis by probiotic but not
commensal enteric bacteria
In view of the markedly higher levels of NSMAse activity
generated by the two probiotic compared to the two non-probiotic
bacterial sonicates, we next tested the ability of each bacterium to
induce apoptosis of mucosal immune cells. In the absence of
bacteria, LPMC exhibited a low rate of spontaneous apoptosis,
with no differences among control, UC and CD cells (Fig. 2a, b).
Exposure of LPMC to the probiotic L. brevis sonicate resulted in an
increased rate of apoptosis (p,0.001) both in control and IBD
cells, the increase being significantly (p,0.05) greater for UC and
CD compared to control LPMC (Fig. 2a). Similarly, S. thermophilus
also resulted in an increased LPMC apoptosis (p,0.01), however,
this increase was significant (p,0.05) only in UC and CD, but not
control cultures (Fig. 2a). When the same control, UC and CD
cells were exposed to the non-probiotic, non-pathogenic gut
Figure 1. Neutral SMAse activity of bacterial sonicates. Neutral SMAse activity was quantified in L. brevis, S. thermophilus, E. coli and E. faecalis
sonicates. SMAse activity of each bacterial sonicate is expressed as relative SMAse activity, assigning an arbitrary value of 100 to the mean SMAse
activity of L. brevis sonicates. Each bar represents 3 separate experiments. *p,0.01 vs. E. coli and E. faecalis.
doi:10.1371/journal.pone.0016953.g001
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commensal E. coli or E. faecalis sonicates, no significant effect on
LPMC apoptosis was found (Fig. 2a, b). The pro-apoptotic effect
of L. brevis and S. thermophilus was confirmed in an additional set of
experiments in which apoptosis was assessed by double staining
with annexin V and propidium iodide (Fig. 2c).
Influence of the cell activation on probiotic-induced
immune cell apoptosis
The observation that the magnitude of probiotic-induced
apoptosis was significantly greater for UC and CD than control
LPMC suggests that mucosal cell activation, as found in IBD, may
be involved in the process of probiotic-induced apoptosis. To test
this hypothesis, we activated freshly isolated control LPMC with
anti-CD3/CD28 antibodies for increasing periods of time prior to
their exposure to bacterial sonicates. Engagement of the CD3/
CD28 pathways resulted in a marked, time-dependent, and
significant enhancement of both L. brevis and S. thermophilus-
induced LPMC apoptosis compared to cultures with no bacteria
(p,0.01–0.001) and unstimulated LPMC (p,0.05–0.01) (Fig. 3a).
Interestingly, E. coli was unable to upregulate apoptosis of
activated LPMC (Fig. 3a). To ascertain whether the ability of
undergoing probiotic-induced, activation-dependent apoptosis was
a distinctive property of LPMC, freshly isolated PBMC were used
as an alternate source of immune cells. After activation with anti-
CD3/CD28, the pattern of PBMC pro-apoptotic response to both
L. brevis and S. thermophilus resembled that observed with LPMC
(p,0.05–0.01) (Fig. 3b), confirming that cell activation has a
definitive role in probiotic-induced immune cell apoptosis.
Induction of apoptosis by exogenous ceramide and
NSMAse
Having detected marked differences in the NSMase activity
between probiotic and non-probiotic bacterial sonicates, we next
undertook a series of experiments aimed at ascertaining whether
the addition of exogenous ceramide to immune cells could
reproduce the pro-apoptotic effect observed with probiotic
bacteria. Exposure of control, UC and CD LPMC to a pre-
determined optimal ceramide concentration (30 mg/mL) resulted
Figure 2. Induction of LPMC apoptosis by bacterial sonicates. A) Control, UC, and CD LPMC were left alone or exposed to L. brevis, S.
thermophilus, E. coli or E. faecalis sonicates for 24 hours, after which the percentage of apoptotic cells was assessed by PI staining and flow cytometric
analysis. Each bar represents 23 control, 7 UC, and 10 CD separate LPMC isolates. * p,0.01 and ** p,0.001 vs. no bacteria; # p,0.05 vs. control
LPMC. B) Flow cytometric analysis of control (upper panel) and CD (lower panel) PI-stained LPMC. Figure is representative of 23 control, and 10 CD
separate LPMC isolates. C) Flow cytometric analysis of control (left panels) and CD (right panels) Annexin V and PI-stained LPMC. Figure is
representative of 4 control, and 4 CD separate LPMC isolates.
doi:10.1371/journal.pone.0016953.g002
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Figure 3. Effect of cell activation on probiotic-induced mononuclear cell apoptosis. A) Control LPMC were left untreated or activated with
combined anti-CD3/CD28 for 24, 48 or 72 hours. Subsequently, cells were exposed to L. brevis, S. thermophilus, or E. coli sonicates for 24 hours, after
which the percentage of apoptotic cells was assessed. Each bar represents 4 separate experiments. * p,0.01 and ** p,0.001 vs. no bacteria;# p,0.05
and ## p,0.01 vs. unstimulated LPMC. B) Control PBMC were left untreated or activated with combined anti-CD3/CD28 for 24, 48 or 72 hours.
Subsequently, cells were exposed to L. brevis, S. thermophilus, or E. coli sonicates for 24 hours, after which the percentage of apoptotic cells was assessed.
Each bar represents 4 separate experiments. * p,0.01 and ** p,0.001 vs. no bacteria; # p,0.05 and ## p,0.01 vs. unstimulated PBMC.
doi:10.1371/journal.pone.0016953.g003
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in a significant increase of the number of apoptotic cells in all
groups (p,0.01–0.001) (Fig. 4a). Of note, the degree of apoptosis
was significantly greater (p,0.05) in UC and CD than control
LPMC (Fig. 4a). Dihydroceramide, the inactive precursor of
ceramide, failed to induce apoptosis in LPMC regardless of their
source either from control, UC or CD patients (Fig. 4a). A similar
effect was observed when LPMC were exposed to a pre-
determined optimal concentration of Bacillus cereus-derived
NSMAse (data not shown). The pro-apoptotic effect of NSMase
required Mg2+ supplementation. Ceramide also induced apoptosis
in activated LPMC and PBMC (p,0.05) compared to unstimu-
lated cells (see below). Thus, these findings underscore that
exogenous ceramide and NSMase reproduce the effects of
probiotic sonicates in activated mucosal cells.
Effect of the cell activation state on ceramide-induced
apoptosis
As demonstrated above, cell activation enhanced the degree of
probiotic-induced apoptosis. To further corroborate that this effect
was mediated by the NSMse/ceramide pathway, we evaluated the
effect of cell activation on ceramide-mediated apoptosis following
incubation with CD3/CD28 antibodies for 24–72 hours. Anti-
CD3/CD28 activation resulted in a marked and time-dependent
enhancement of ceramide-induced LPMC apoptosis (Fig. 4b),
mimicking the previously observed increase in apoptosis of anti-
CD3/CD28-activated LPMC by L. brevis and S. thermophilus
(p,0.05–0.01). The pro-apoptotic effect of ceramide was also
noted with activated PBMC (p,0.05–0.01) (Fig. 4c).
Activation of JNK and production of ROS in probiotic-
triggered LPMC apoptosis
Because ceramide activates stress-activated protein kinases, like
c-jun N-terminal kinase (JNK) [26], we investigated whether
exposure of control LPMC to L. brevis resulted in JNK activation.
In a first series of experiments we found that exposure to L. brevis
sonicates increased JNK phosphorylation in treated compared to
untreated LPMC (Fig. 5a). In contrast, no increase in JNK
phosphorylation was observed when LPMC were exposed to
sonicates of the non-probiotic bacteria E. coli. JNK was not
detected in L. brevis or E. coli sonicates (Fig. 5a). In a second series
of experiments, we tested the effect of exogenous NSMase, and we
also observed a time-dependent phosphorylation of JNK in LPMC
that mimicked the results obtained with L. brevis sonicates (Fig. 5b).
Together, these results further support the involvement of the
NSMAse/ceramide pathway in probiotic-induced LPMC apop-
tosis. Treatment of L. brevis sonicates with the specific JNK
inhibitor SP-600125 did not prevent the induction of LPMC
apoptosis by L. brevis sonicates (data no shown), suggesting that
other nSMAse-mediated, signalling pathways are able to forward
the pro-apoptotic signal.
Another hallmark of ceramide-mediated cell signalling is the
production of reactive oxygen species (ROS) [27,28,29]. Exposure
of control LPMC to L. brevis sonicates resulted in a 3-fold increase
(p = 0.02) in ROS production compared to untreated cells
(Fig. 6a). On the contrary, treatment of the same LPMC with
sonicates of the non-probiotic bacteria E. coli failed to significantly
change LPMC ROS production compared to untreated cells
(Fig. 6a). Panels b, c and d in Fig. 6 are representative flow
cytometry analyses of control LPMC incubated with no bacteria,
L. brevis or E. coli sonicates, respectively. Similar results were
obtained when control LPMC were exposed to bacterial sonicates
for 60 minutes (data not shown). These results show that ROS are
generated during LPMC apoptosis mediated by probiotic
nSMAse, further supporting the involvement of the NSMAse/
ceramide pathway in this process. Treatment of L. brevis sonicates
with the phenolic antioxidant butylated hydroxyanisole (BHT),
which prevents ROS production, did not influence the induction
of LPMC apoptosis by L. brevis sonicates (data no shown),
suggesting that other NSMAse-mediated, signalling pathways are
able to forward the pro-apoptotic signal.
Blockade of probiotic-induced cell death by inhibition of
NSMAse activity
The results so far point to NSMAse as the mediator responsible
for the pro-apoptotic effects of probiotic bacterial sonicates. To
confirm this notion, we performed a series of blocking experiments
using GSH, which is known to inhibit NSMase [30]. When control
LPMC were exposed to sonicates of either L. brevis or S. thermophilus
previously preincubated with GSH, a complete abrogation of the
sonicates’ pro-apoptotic effect was observed (p,0.05) (Fig. 7a). A
similar effect was also observed with CD LPMC, with a significant
(p,0.05) reduction in the percentage of apoptotic cells with both
L. brevis and S. thermophilus GSH-treated sonicates (Fig. 7b). In
contrast, preincubation of E. coli or E. faecalis sonicates with GSH
had no significant modulatory effect on control or CD LPMC
apoptosis (Fig. 7a,b). GSH also inhibited the pro-apoptotic effect
of L. brevis and S. thermophilus on resting and CD3/CD28-activated
PBMC (Fig. 7c). Although the capacity of GSH to abrogate the
activity of NSMase is well established, GSH could have other
effects on bacterial sonicates that might affect cell apoptosis.
Therefore, we undertook additional experiments using GW4869, a
specific inhibitor of NSMase [31]. Preincubation of L. brevis
sonicates with various concentrations of GW4869 resulted in a
clear dose-dependent inhibition of NSMase activity (p,0.05–0.01)
(Fig. 8a). When an optimal inhibitory dose of GW4869 was added
to L. brevis sonicates a marked and significant (p,0.05–0.01)
reduction of their capacity to induce LPMC apoptosis was
observed, more so for UC and CD than control LPMC
(Fig. 8b). The combined results of the blocking experiments
confirm the essential role of the NSMAse/ceramide pathway in
mediation of probiotic-induced LPMC apoptosis.
Discussion
The molecular mechanisms of the beneficial effects of probiotics
remain to be fully elucidated. Recent observations showed that
VSL#3, a probiotic containing a mixture of bacteria, stimulated
mucosal alkaline sphingomyelinase and reduced inflammation
[22]. However, the underlying mechanisms and downstream
targets for the putative role of alkaline sphingomyelinase in
mediating the therapeutic effects of probiotics were not charac-
terized [22]. The present study shows that L. brevis and S.
thermophilus, two probiotic bacterial sonicates, can induce apoptosis
of mucosal immune cells through the SMAse/ceramide pathway.
This effect is not shared by E. coli and E. faecalis, the two non-
probiotic enteric bacterial sonicates studied, suggesting that the
ability to kill immunocytes is restricted to bacterial strains
containing sufficient quantities of the key enzyme NSMase. We
show that extracts of the probiotic L. brevis or S. thermophilus
induced apoptosis of systemic and mucosal immune cells. Not only
was this effect greater in magnitude than that of the non-probiotic
E. coli or E. faecalis, but was also greater for LPMC from IBD than
control non-IBD mucosa. Because IBD cells are in an enhanced
state of activation, activation or differentiation may be a
requirement to render immune cells susceptible to the pro-
apoptotic effect of probiotics. This appears to be the case, as CD3/
CD28-stimulated LPMC and PBMC displayed increased apopto-
Probiotics and NSMase in Inflammatory Bowel Disease
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sis upon exposure to L. brevis or S. thermophilus sonicates. The degree
of cell activation, as determined by the duration of CD3/CD28
stimulation, correlated closely with the amount of mononuclear
cell apoptosis, underscoring the importance of cell activation for
probiotic-mediated cell death. These results are in keeping with
previous evidence showing a tight relationship between immune
cell activation and apoptosis. Activation-induced cell death is a
complex physiological event aimed at deleting an excess of
activated lymphocytes to prevent autoimmunity or uncontrolled
immune reactivity [18,32]. The relevance of this mechanism to
autoimmunity prevention and maintenance of tolerance is
exemplified by the development of autoimmune diseases in mice
and humans with inherited defects in Fas or FasL [33,34].
Because probiotics are live bacteria with a vast array of
components and functions, the exact mechanisms explaining the
beneficial effects are complex and difficult to dissect. If the
capacity to induce immune cells apoptosis is an exclusive property
of some probiotic bacteria, as found in the present study, certain
products with the ability to induce apoptosis should be
predominantly expressed by these probiotics. The striking
quantitative difference in NSMAse activity between the two
probiotic and the two commensal bacterial sonicates included in
our study clearly points towards this enzyme as the likely culprit
for the pro-apoptotic action of L. brevis and S. thermophilus. To test
this possibility a series of experiments was carried out.
First, L. brevis and S. thermophilus but not E.coli or E. faecalis
sonicates exhibited enhanced NSMase activity. Further, we
demonstrated that exposure of resting and activated PBMC and
LPMC, to either exogenous ceramide or recombinant NSMAse
results in a marked enhancement of cell apoptosis, mimicking the
effect seen with the probiotic strains L. brevis and S. thermophilus. As
negative control, the inactive sphyngolipid dihydroceramide, failed
to induce apoptosis. Corroborating evidence was obtained by
showing that the level of ceramide-induced apoptosis was also
dependent of the degree of immune cell activation.
Second, we investigated some of the ceramide-triggered
pathways during probiotic-induced mononuclear cell apoptosis.
Signalling downstream of ceramide is extremely complex, but two
of the best-known pathways involve JNK activation [26,35] and
ROS production [27,36]. As we hypothesised, phosphorylation of
JNK was observed after exposure of LPMC to L. brevis, but not to
the commensal E. faecalis. Of note, exposure of LPMC to
recombinant NSMAse also induced JNK activation, and to a
similar degree than L. brevis sonicates. Likewise, L. brevis, but not E.
faecalis, induced a four-fold increase in ROS production by LPMC.
The selectivity of L. brevis effects on JNK activation and ROS
Figure 4. Induction of mononuclear cell apoptosis by exogenous ceramide. A) Control, UC, and CD LPMC were left untreated or cultured
with ceramide or dihydroceramide for 24 hours, after which the percentage of apoptotic cells was assessed. Each bar represents 23 control, 7 UC, or
10 CD separate LPMC isolates. * p,0.01 and ** p,0.001 vs. no bacteria; # p,0.05 vs. control LPMC. B) Control LPMC were left untreated or activated
with combined anti-CD3/CD28 for 24, 48 or 72 hours. Subsequently, cells were cultured with ceramide or dihydroceramide for 24 hours, after which
the percentage of apoptotic cells was assessed. Each bar represents 4 separate experiments. * p,0.05 and ** p,0.01 vs. no bacteria; # p,0.05 vs.
unstimulated LPMC. C) Control PBMC were left untreated or activated with combined anti-CD3/CD28 for 24, 48 or 72 hours. Subsequently, cells were
cultured with ceramide or dihydroceramide for 24 hours, after which the percentage of apoptotic cells was assessed. Each bar represents 4 separate
experiments. * p,0.05 and ** p,0.01 vs. no bacteria; # p,0.05 and ## p,0.01 vs. unstimulated PBMC.
doi:10.1371/journal.pone.0016953.g004
Figure 5. L. brevis-induced JNK phosphorylation by LPMC. A) L. brevis- but not E.coli-induced phosphorylation of JNK in LPMC. Control LPMC
were left alone or exposed to L. brevis or E. coli sonicates for 30 minutes or 2 hours, after which JNK phosphorylation was assessed. JNK is not
detected in L. brevis or E. coli sonicates (two last lanes on the right). B) Exogenous nSMAse-induced phosphorylation of JNK in LPMC. Control LPMC
were left alone or exposed to L. brevis or recombinant neutral SMAse for 15, 30 or 60 minutes, after which JNK phosphorylation was assessed. LB = L.
brevis sonicates; EC = E. coli sonicates; nS = nSNAse. Figure is representative of 3 separate experiments.
doi:10.1371/journal.pone.0016953.g005
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formation bolster the notion that NSMAse, present in large
quantities in probiotics, and its product ceramide are intimately
involved in the process of probiotic-induced immune cell
apoptosis. The fact that neither JNK nor ROS production
blockade separately were able to prevent probiotic sonicate-
induced LPMC apoptosis reflects the complexity of signalling
downstream of ceramide, suggesting the existence of redundant
pathways to forward the pro-apoptotic signal. For instance, in
addition to JNK/ROS, ceramide (independently of its mechanism
of generation) can target other cell death regulators, such as
cathepsin D or protein phosphatase PP1 or PP2, among others
[19].
Third, we investigated the consequences of NSMAse inhibition,
which should result in a reduction of the probiotic pro-apoptotic
capacity. Preincubation of L. brevis and S. thermophilus sonicates with
optimal concentrations of GSH, a potent inhibitor of NSMAse
activity [30], markedly reduced apoptosis. A potential limitation to
the interpretation of these results is that GSH, besides nSMAse
inhibition, could influence the ability of probiotic sonicates to
induce apoptosis by modifying the redox state [37]. To address
this issue, we used the highly specific nSMAse inhibitor GW4869,
which does not influence the redox state [31]. GW4869 almost
completely abrogated in a dose-dependent fashion the nSMAse
activity of L.brevis, the strain with the highest SMAse activity.
Additionally, pre-incubation of L. brevis sonicates with optimal
doses of GW4869 obviously reduced L. brevis-induced LPMC
apoptosis, an inhibitory effect more evident for IBD than control
LPMC.
Our results cannot be extrapolated to all probiotic agents
described to date, since only two of them, L. brevis and S.
thermophilus, were evaluated in our study. The fact that other
probiotic microorganisms might have low or absent NSMAse
activity, a key molecule for probiotic-induced immune cell
apoptosis, as shown in our study, implies that the assessment of
NSMAse activity may have clinical applications, helping the
investigators to select the best probiotics to be tested in IBD.
The relevance of our findings mostly rests on the concept that
resistance of mucosal immune cells to apoptosis is considered an
essential component of IBD pathogenesis (17), probably in
combination with an excessive cell proliferation [38,39]. The
clinical relevance of immune cell apoptosis in IBD is supported by
evidence showing that induction of apoptosis is a mechanism
common to most IBD therapies, including aminosalycilates (12),
steroids (13), immunosupressants [40], and infliximab [41]. In
Figure 6. L. brevis-induced reactive oxygen species production by LPMC. Left panel (A): control LPMC were left alone or exposed to L. brevis
or E. coli sonicates for 30 minutes, after which production of reactive oxygen species by LPMC was assessed. Data are expressed as mean fluorescence
intensity of LPMC. Each bar represents 5 separate experiments. *p = 0.02 vs. no bacteria; #p = 0.04 vs. E. coli. Right panel: Flow cytometric analysis of
control LPMC. Cells were left alone (B) or exposed to L. brevis (C) or E. coli (D) sonicates for 30 minutes, after which production of reactive oxygen
species by LPMC was quantified and expressed as mean fluorescence intensity. Figures are representative of 5 separate experiments.
doi:10.1371/journal.pone.0016953.g006
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conclusion, the ability of L. brevis and S. thermophilus to promote
apoptosis may compensate the deficient cell death and thus
contribute to re-establish mucosal immune homeostasis and
decrease inflammation in IBD-involved intestine.
Materials and Methods
Bacterial strains and preparation of bacterial sonicates
Bacterial strains used in this study included the probiotic
bacteria L. brevis (CD2; DSM#11988; Deutsche Sammlung von
Mikroornanisgmen und Zellkulturen, Braunschweig, Germany)
and S. termophilus (CD8; DSM#14667), and the non-probiotic non-
pathogenic bacteria E. coli (ATCC#49420; ATCC, Manassas,
VA) and E. faecalis (ATCC#700802; ATCC). Bacterial suspen-
sions were prepared from cultures of each individual strain. L.
brevis and S. thermophilus were grown in De Man Rogosa Sharp
medium (MRS; Difco, Detroit, MI). E.coli and E. faecalis were
grown in a 1% tryptone peptone medium (Difco), 0.5% NaCl, and
0.5% yeast extract (Difco). Bacteria were harvested at the end of
logarithmic phase by centrifugation, suspended in four times their
Figure 7. Inhibition of L. brevis-induced cell apoptosis by glutathione. A) Control LPMC were left alone, exposed to L. brevis, S. thermophilus,
E. coli or E. faecalis sonicates, or bacterial sonicates previously treated with 5 mM glutathione for 24 hours, after which the percentage of apoptotic
cells was assessed. B) CD LPMC were left alone, exposed to L. brevis, S. thermophilus, E. coli or E. faecalis sonicates, or bacterial sonicates previously
treated with 5 mM glutathione for 24 hours, after which the percentage of apoptotic cells was assessed. C) Control PBMC were left unstimulated or
activated with combined anti-CD3/CD28 for 24, 48 or 72 hours. Subsequently, cells were exposed to L. brevis or S. thermophilus sonicates, or to
bacterial sonicates previously treated with 5 mM glutathione for 24 hours, after which the percentage of apoptotic cells was assessed. Each bar
represents 4 separate experiments. * p,0.05 and ** p,0.01 vs. no bacteria; # p,0.05 vs. no glutathione.
doi:10.1371/journal.pone.0016953.g007
Figure 8. Specific inhibition of L. brevis-induced cell apoptosis by GW4869. A) L. brevis sonicates were exposed to increasing concentrations
of GW4869. SMAse activity of each bacterial sonicate is expressed as relative SMAse activity, assigning an arbitrary value of 100 to the mean SMAse
activity of L. brevis sonicates. Each bar represents 3 separate experiments. * p,0.05 and ** p,0.01 vs. no GW4869. B) Control LPMC were left alone or
exposed to L. brevis sonicates previously treated with different doses of GW4869 for 24 hours, after which the percentage of apoptotic cells was
assessed. Each bar represents 4 separate LPMC isolates. * p,0.05 and ** p,0.01 vs. no bacteria; # p,0.05 and ## p,0.01 vs. no GW4869.
doi:10.1371/journal.pone.0016953.g008
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wet weight in desintegration buffer containing (7.8 g/l NaH2PO4,
7.1 g/l Na2HPO4, 0.247 g/l MgSO467H2O, 1 mM EDTA,
1 mM DTT, proteases inhibitors, and triton) and, after three
freeze-thaw cycles, sonicated (30 min, alternating 10 s of sonica-
tion and 10 s of pause) with a Vibracell sonicator (Sonic and
Materials, Danbury, CT).
Isolation of human LPMC and PBMC
Lamina propria mononuclear cells (LPMC) were isolated from
surgical specimens obtained from patients admitted for bowel
resection for UC and CD, while malignant and nonmalignant
conditions provided histologicaly normal control tissue. All
diagnoses were confirmed by clinical, radiologic, endoscopic,
and histologic criteria. LPMC were isolated as previously
described [42]. Blood samples were collected from patients with
UC and CD, as well as healthy subjects. Peripheral blood
mononuclear cells (PBMC) were isolated from heparinized venous
blood, using a Ficoll-Hypaque density gradient, as previously
reported [43]. This project was approved by the Institutional
Review Board of University Hospitals of Cleveland and Hospital
Clinic i Provincial of Barcelona.
Flow-cytometric characterization of mononuclear cell
apoptosis
A series of preliminary studies were carried out to ascertain the
optimal concentration of bacterial sonicates and time of exposure
of mononuclear cells to induce apoptosis. In subsequent
experiments, bacterial sonicates were added to mononuclear cell
cultures at a concentration of 1 mg protein of bacterial sonicate/
106 cells/ml, for 24 h. Apoptosis and cell cycle phase distribution
were analyzed by propidium iodide staining followed by flow
cytometry, as previously described [38]. Where indicated, LPMC
and PBMC were pre-stimulated with CD3 monoclonal antibody
(mAb) (OKT3; Ortho Diagnostic System INC., Raritan, NJ) and
CD28 mAb (Pharmingen Biosciences, San Diego, CA, USA) for
different periods of time (24, 48 or 72 hours) before exposure to
the bacterial sonicates. Similarly, where indicated, L. brevis
sonicates were preincubated for 30 min with 5 mM glutathione
(GSH) (Calbiochem) or various concentrations of the specific
NSMAse Inhibitor GW4869 (Sigma, St. Louis, MO), before
addition to the cell cultures. In an additional set of experiments,
apoptosis was assessed by combined annexin V/propidium iodide
staining (Dako, Glostrup, Deenmark), according to the manufac-
turer’s instructions. In some cases, LPMC and PBMC were
incubated with various concentrations of C2-ceramide (Biomol
International, Plymouth Meeting, PA), the inactive sphingolipid
dihydroceramide (Biomol International), or nSMase from Bacillus
cereus (Sigma) and examined for apoptosis as described above.
Quantification of the NSMase activity of bacterial
sonicates
Lyophilized bacteria (10 mg) were resuspended and sonicated as
described above. Protein concentration was determined by the
microbicinchoninic acid assay kit (Pierce, Rockford, IL) with
bovine serum albumin standards. Different amounts of bacterial
sonicates (1, 0.5, and 0.25 mg) in 50 mM Tris?HCl buffer, pH 7.4,
containing 5 mM MgCl2 and [N-methyl-14C]sphingomyelin
(0.28 mCi/ml, specific activity 55 mCi/mmol; Amersham, Buck-
inghamshire, UK), were used for determination of NSMase
activity as described before [44]. Alternatively, NSMase activity
was also determined by incubating extracts with C6-7-nitro-2,1,3-
benzoxadiazol-4-yl (NBD)-sphingomyelin analyzing NBD-cer-
amide by TLC [45]. Determination of ceramide levels was
performed by the diacylglycerol (DAG) kinase assay as described
[27]. In some instances, ceramide levels were analyzed by HPLC
after deriatization of the sphingoid base with O-phthaldehyde
following deacylation of ceramide as described previously [46].
Where indicated, the bacterial preparations were preincubated for
30 min with 5 mM GSH [30] or various concentrations of
GW4869 to inhibit nSMase activity, as previously described [31].
JNK activation in LPMC
At the end of 24 hr culture with bacterial sonicates, cells were
washed, lysed and 40 mg of protein were run on a 10% SDS-
PAGE and transferred onto a nitrocellulose membrane at 140 mA
in 25 mM Tris-HCl, pH 8.3, 192 mM glycine, and 20%
methanol. To study the activation of JNK, western blot analysis
was performed using an anti-phosphorylated JNK antibody,
dilution 1:1000 (Pharmingen Biosciences, San Diego, CA),
according to the manufacturer’s instructions. In additional
experiments, we also assessed the functional impact of JNK
blockade on probiotic sonicates-induced LPMC apoptosis. The
specific JNK inhibitor SP-600125 was purchased from Calbio-
chem (San Diego, CA, USA) and dissolved in dimethyl sulfoxide
(DMSO, Sigma-Aldrich). Stock solutions of at least 20 mM were
made. L. brevis sonicates were incubated with SP-600125 for
30 minutes, before its addition to LPMC cultures. LPMC
apoptosis and cell cycle phase distribution were analyzed by PI
staining followed by flow cytometry, as described above.
Reactive oxygen species (ROS) production in LPMC
Hydrogen peroxide was measured by cytometry using chlor-
omethyl-29-79-dichlorofluorescein diacetate (DCF; Invitrogen Mo-
lecular Probes, Eugene, OR). LPMC were incubated with the
fluorescent probe at 2 mM, in the absence or presence of bacterial
sonicates. Fluorescence was determined at 529 nm for emission
and 503 nm for excitation, with slit widths of 10 and 5 nm,
respectively, after 30 and 60 minutes of LPMC exposure to
bacterial sonicates [47,48]. Fluorescence of DCF was correlated
with increasing concentrations of hydrogen peroxide allowing
determination of hydrogen peroxide, as described [47]. In
additional experiments, we also assessed the functional impact of
ROS production blockade on probiotic sonicates-induced LPMC
apoptosis. To prevent ROS production the phenolic antioxidant
butylated hydroxyanisole (BHT) was obtained from Sigma (St.
Louis, MO, USA) and added to bacterial sonicates for 30 minutes,
before its addition to LPMC cultures. LPMC apoptosis and cell
cycle phase distribution were analyzed by PI staining followed by
flow cytometry, as described above.
Statistical Analysis
Data were analyzed by Stat View software (SAS Institute Inc.,
Cary, NC) using the non-parametric Kruskall-Wallis and Mann-
Whitney tests. Repeated measures for the same subject were
analyzed by using the Student paired t test. Values are expressed as
the mean 6 SEM. Statistical significance was set at a P value of
less than 0.05.
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